Related Experiment Video
Updated: Feb 8, 2026

DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat
Published on: February 27, 2014
Longitudinal Changes in Symptom Cluster Membership in Inflammatory Bowel Disease
Samantha Conley1, Sangchoon Jeon2, Deborah D Proctor3
1Delta Mu, Postdoctoral Fellow, Yale School of Nursing, West Haven, CT, USA.
Symptom clusters in inflammatory bowel disease (IBD) patients remained stable over one year. Remission from active disease shifted patients from high symptom burden to low burden or psychological symptom groups.
Area of Science:
- Gastroenterology and Immunology
- Patient-Reported Outcomes
- Chronic Disease Management
Background:
- Inflammatory bowel disease (IBD) presents with complex symptom clusters.
- Understanding the trajectory of these symptom clusters is crucial for effective patient management.
- Previous research has not fully elucidated the stability and predictors of change in IBD symptom clusters.
Purpose of the Study:
- To describe changes in symptom cluster membership over one year in adults with IBD.
- To identify demographic and clinical factors predicting transitions between symptom clusters.
Main Methods:
- Retrospective longitudinal study using the Crohn's & Colitis Foundation of America Partners Cohort (2012-2015).
- Latent transition analysis assessed symptom cluster changes at baseline, 6, and 12 months.
- Multinomial regressions examined predictors of cluster transition, measuring pain, fatigue, sleep, depression, and anxiety.
Main Results:
- Four stable symptom clusters were identified: high symptom burden (32.3%-35.3%), low symptom burden (24.2%-27.1%), physical symptoms (19.0%-20.9%), and psychological symptoms (20.0%-21.5%).
- High stability was observed, with probabilities of remaining in the same cluster ranging from .814 to .905.
- Transition from active disease to remission was associated with shifts from high burden to low burden and psychological symptom clusters.
Conclusions:
- Symptom cluster membership in IBD patients demonstrates significant stability over a one-year period.
- Further research is needed to understand the etiology of these clusters and develop targeted interventions.
- Personalized symptom management strategies that address multiple symptoms are recommended for IBD patients.
More Related Videos
Related Concept Videos
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Longitudinal Research

